Global Medical Topical Hemostatic Agent Supply, Demand and Key Producers, 2023-2029

Page: 109

Published Date: 07 Aug 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Medical Topical Hemostatic Agent market size is expected to reach $ 13610 million by 2029, rising at a market growth of 6.8% CAGR during the forecast period (2023-2029).

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Medical topical hemostatic agent are used in the setting of surgery or trauma as adjuncts to maintain hemostasis. Topical hemostat products include gelatin sponges, collagens, fibrin sealants, and active thrombin preparations. These agents are applied locally to stop blood flow.

This report studies the global Medical Topical Hemostatic Agent production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Medical Topical Hemostatic Agent, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Medical Topical Hemostatic Agent that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Medical Topical Hemostatic Agent total production and demand, 2018-2029, (K Units)
Global Medical Topical Hemostatic Agent total production value, 2018-2029, (USD Million)
Global Medical Topical Hemostatic Agent production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Medical Topical Hemostatic Agent consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Medical Topical Hemostatic Agent domestic production, consumption, key domestic manufacturers and share
Global Medical Topical Hemostatic Agent production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Medical Topical Hemostatic Agent production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Medical Topical Hemostatic Agent production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global Medical Topical Hemostatic Agent market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences and B Braun Melsungen, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Medical Topical Hemostatic Agent market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Medical Topical Hemostatic Agent Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Medical Topical Hemostatic Agent Market, Segmentation by Type
Gelation Sponge
Oxidized Regenerated Cellulose Based Hemostats
Others

Global Medical Topical Hemostatic Agent Market, Segmentation by Application
Hospitals
Surgical Centers
Nursing Homes

Companies Profiled:
Ethicon
Pfizer
Baxter International
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences
B Braun Melsungen
Gelita Medical
Equimedical
Vascular Solutions
Marine Polymer Technologies

Key Questions Answered
1. How big is the global Medical Topical Hemostatic Agent market?
2. What is the demand of the global Medical Topical Hemostatic Agent market?
3. What is the year over year growth of the global Medical Topical Hemostatic Agent market?
4. What is the production and production value of the global Medical Topical Hemostatic Agent market?
5. Who are the key producers in the global Medical Topical Hemostatic Agent market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Medical Topical Hemostatic Agent Introduction
    1.2 World Medical Topical Hemostatic Agent Supply & Forecast
        1.2.1 World Medical Topical Hemostatic Agent Production Value (2018 & 2022 & 2029)
        1.2.2 World Medical Topical Hemostatic Agent Production (2018-2029)
        1.2.3 World Medical Topical Hemostatic Agent Pricing Trends (2018-2029)
    1.3 World Medical Topical Hemostatic Agent Production by Region (Based on Production Site)
        1.3.1 World Medical Topical Hemostatic Agent Production Value by Region (2018-2029)
        1.3.2 World Medical Topical Hemostatic Agent Production by Region (2018-2029)
        1.3.3 World Medical Topical Hemostatic Agent Average Price by Region (2018-2029)
        1.3.4 North America Medical Topical Hemostatic Agent Production (2018-2029)
        1.3.5 Europe Medical Topical Hemostatic Agent Production (2018-2029)
        1.3.6 China Medical Topical Hemostatic Agent Production (2018-2029)
        1.3.7 Japan Medical Topical Hemostatic Agent Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Medical Topical Hemostatic Agent Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Medical Topical Hemostatic Agent Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Medical Topical Hemostatic Agent Demand (2018-2029)
    2.2 World Medical Topical Hemostatic Agent Consumption by Region
        2.2.1 World Medical Topical Hemostatic Agent Consumption by Region (2018-2023)
        2.2.2 World Medical Topical Hemostatic Agent Consumption Forecast by Region (2024-2029)
    2.3 United States Medical Topical Hemostatic Agent Consumption (2018-2029)
    2.4 China Medical Topical Hemostatic Agent Consumption (2018-2029)
    2.5 Europe Medical Topical Hemostatic Agent Consumption (2018-2029)
    2.6 Japan Medical Topical Hemostatic Agent Consumption (2018-2029)
    2.7 South Korea Medical Topical Hemostatic Agent Consumption (2018-2029)
    2.8 ASEAN Medical Topical Hemostatic Agent Consumption (2018-2029)
    2.9 India Medical Topical Hemostatic Agent Consumption (2018-2029)

3 World Medical Topical Hemostatic Agent Manufacturers Competitive Analysis
    3.1 World Medical Topical Hemostatic Agent Production Value by Manufacturer (2018-2023)
    3.2 World Medical Topical Hemostatic Agent Production by Manufacturer (2018-2023)
    3.3 World Medical Topical Hemostatic Agent Average Price by Manufacturer (2018-2023)
    3.4 Medical Topical Hemostatic Agent Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Medical Topical Hemostatic Agent Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Medical Topical Hemostatic Agent in 2022
        3.5.3 Global Concentration Ratios (CR8) for Medical Topical Hemostatic Agent in 2022
    3.6 Medical Topical Hemostatic Agent Market: Overall Company Footprint Analysis
        3.6.1 Medical Topical Hemostatic Agent Market: Region Footprint
        3.6.2 Medical Topical Hemostatic Agent Market: Company Product Type Footprint
        3.6.3 Medical Topical Hemostatic Agent Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Medical Topical Hemostatic Agent Production Value Comparison
        4.1.1 United States VS China: Medical Topical Hemostatic Agent Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Medical Topical Hemostatic Agent Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Medical Topical Hemostatic Agent Production Comparison
        4.2.1 United States VS China: Medical Topical Hemostatic Agent Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Medical Topical Hemostatic Agent Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Medical Topical Hemostatic Agent Consumption Comparison
        4.3.1 United States VS China: Medical Topical Hemostatic Agent Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Medical Topical Hemostatic Agent Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Medical Topical Hemostatic Agent Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Medical Topical Hemostatic Agent Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Medical Topical Hemostatic Agent Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Medical Topical Hemostatic Agent Production (2018-2023)
    4.5 China Based Medical Topical Hemostatic Agent Manufacturers and Market Share
        4.5.1 China Based Medical Topical Hemostatic Agent Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Medical Topical Hemostatic Agent Production Value (2018-2023)
        4.5.3 China Based Manufacturers Medical Topical Hemostatic Agent Production (2018-2023)
    4.6 Rest of World Based Medical Topical Hemostatic Agent Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Medical Topical Hemostatic Agent Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Medical Topical Hemostatic Agent Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Medical Topical Hemostatic Agent Production (2018-2023)

5 Market Analysis by Type
    5.1 World Medical Topical Hemostatic Agent Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Gelation Sponge
        5.2.2 Oxidized Regenerated Cellulose Based Hemostats
        5.2.3 Others
    5.3 Market Segment by Type
        5.3.1 World Medical Topical Hemostatic Agent Production by Type (2018-2029)
        5.3.2 World Medical Topical Hemostatic Agent Production Value by Type (2018-2029)
        5.3.3 World Medical Topical Hemostatic Agent Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Medical Topical Hemostatic Agent Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospitals
        6.2.2 Surgical Centers
        6.2.3 Nursing Homes
    6.3 Market Segment by Application
        6.3.1 World Medical Topical Hemostatic Agent Production by Application (2018-2029)
        6.3.2 World Medical Topical Hemostatic Agent Production Value by Application (2018-2029)
        6.3.3 World Medical Topical Hemostatic Agent Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Ethicon
        7.1.1 Ethicon Details
        7.1.2 Ethicon Major Business
        7.1.3 Ethicon Medical Topical Hemostatic Agent Product and Services
        7.1.4 Ethicon Medical Topical Hemostatic Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Ethicon Recent Developments/Updates
        7.1.6 Ethicon Competitive Strengths & Weaknesses
    7.2 Pfizer
        7.2.1 Pfizer Details
        7.2.2 Pfizer Major Business
        7.2.3 Pfizer Medical Topical Hemostatic Agent Product and Services
        7.2.4 Pfizer Medical Topical Hemostatic Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Pfizer Recent Developments/Updates
        7.2.6 Pfizer Competitive Strengths & Weaknesses
    7.3 Baxter International
        7.3.1 Baxter International Details
        7.3.2 Baxter International Major Business
        7.3.3 Baxter International Medical Topical Hemostatic Agent Product and Services
        7.3.4 Baxter International Medical Topical Hemostatic Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Baxter International Recent Developments/Updates
        7.3.6 Baxter International Competitive Strengths & Weaknesses
    7.4 C. R. Bard
        7.4.1 C. R. Bard Details
        7.4.2 C. R. Bard Major Business
        7.4.3 C. R. Bard Medical Topical Hemostatic Agent Product and Services
        7.4.4 C. R. Bard Medical Topical Hemostatic Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 C. R. Bard Recent Developments/Updates
        7.4.6 C. R. Bard Competitive Strengths & Weaknesses
    7.5 The Medicines Company
        7.5.1 The Medicines Company Details
        7.5.2 The Medicines Company Major Business
        7.5.3 The Medicines Company Medical Topical Hemostatic Agent Product and Services
        7.5.4 The Medicines Company Medical Topical Hemostatic Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 The Medicines Company Recent Developments/Updates
        7.5.6 The Medicines Company Competitive Strengths & Weaknesses
    7.6 Anika Therapeutics
        7.6.1 Anika Therapeutics Details
        7.6.2 Anika Therapeutics Major Business
        7.6.3 Anika Therapeutics Medical Topical Hemostatic Agent Product and Services
        7.6.4 Anika Therapeutics Medical Topical Hemostatic Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Anika Therapeutics Recent Developments/Updates
        7.6.6 Anika Therapeutics Competitive Strengths & Weaknesses
    7.7 Advanced Medical Solutions
        7.7.1 Advanced Medical Solutions Details
        7.7.2 Advanced Medical Solutions Major Business
        7.7.3 Advanced Medical Solutions Medical Topical Hemostatic Agent Product and Services
        7.7.4 Advanced Medical Solutions Medical Topical Hemostatic Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Advanced Medical Solutions Recent Developments/Updates
        7.7.6 Advanced Medical Solutions Competitive Strengths & Weaknesses
    7.8 Integra LifeSciences
        7.8.1 Integra LifeSciences Details
        7.8.2 Integra LifeSciences Major Business
        7.8.3 Integra LifeSciences Medical Topical Hemostatic Agent Product and Services
        7.8.4 Integra LifeSciences Medical Topical Hemostatic Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Integra LifeSciences Recent Developments/Updates
        7.8.6 Integra LifeSciences Competitive Strengths & Weaknesses
    7.9 B Braun Melsungen
        7.9.1 B Braun Melsungen Details
        7.9.2 B Braun Melsungen Major Business
        7.9.3 B Braun Melsungen Medical Topical Hemostatic Agent Product and Services
        7.9.4 B Braun Melsungen Medical Topical Hemostatic Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 B Braun Melsungen Recent Developments/Updates
        7.9.6 B Braun Melsungen Competitive Strengths & Weaknesses
    7.10 Gelita Medical
        7.10.1 Gelita Medical Details
        7.10.2 Gelita Medical Major Business
        7.10.3 Gelita Medical Medical Topical Hemostatic Agent Product and Services
        7.10.4 Gelita Medical Medical Topical Hemostatic Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Gelita Medical Recent Developments/Updates
        7.10.6 Gelita Medical Competitive Strengths & Weaknesses
    7.11 Equimedical
        7.11.1 Equimedical Details
        7.11.2 Equimedical Major Business
        7.11.3 Equimedical Medical Topical Hemostatic Agent Product and Services
        7.11.4 Equimedical Medical Topical Hemostatic Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 Equimedical Recent Developments/Updates
        7.11.6 Equimedical Competitive Strengths & Weaknesses
    7.12 Vascular Solutions
        7.12.1 Vascular Solutions Details
        7.12.2 Vascular Solutions Major Business
        7.12.3 Vascular Solutions Medical Topical Hemostatic Agent Product and Services
        7.12.4 Vascular Solutions Medical Topical Hemostatic Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.12.5 Vascular Solutions Recent Developments/Updates
        7.12.6 Vascular Solutions Competitive Strengths & Weaknesses
    7.13 Marine Polymer Technologies
        7.13.1 Marine Polymer Technologies Details
        7.13.2 Marine Polymer Technologies Major Business
        7.13.3 Marine Polymer Technologies Medical Topical Hemostatic Agent Product and Services
        7.13.4 Marine Polymer Technologies Medical Topical Hemostatic Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.13.5 Marine Polymer Technologies Recent Developments/Updates
        7.13.6 Marine Polymer Technologies Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Medical Topical Hemostatic Agent Industry Chain
    8.2 Medical Topical Hemostatic Agent Upstream Analysis
        8.2.1 Medical Topical Hemostatic Agent Core Raw Materials
        8.2.2 Main Manufacturers of Medical Topical Hemostatic Agent Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Medical Topical Hemostatic Agent Production Mode
    8.6 Medical Topical Hemostatic Agent Procurement Model
    8.7 Medical Topical Hemostatic Agent Industry Sales Model and Sales Channels
        8.7.1 Medical Topical Hemostatic Agent Sales Model
        8.7.2 Medical Topical Hemostatic Agent Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Medical Topical Hemostatic Agent Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Medical Topical Hemostatic Agent Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Medical Topical Hemostatic Agent Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Medical Topical Hemostatic Agent Production Value Market Share by Region (2018-2023)
    Table 5. World Medical Topical Hemostatic Agent Production Value Market Share by Region (2024-2029)
    Table 6. World Medical Topical Hemostatic Agent Production by Region (2018-2023) & (K Units)
    Table 7. World Medical Topical Hemostatic Agent Production by Region (2024-2029) & (K Units)
    Table 8. World Medical Topical Hemostatic Agent Production Market Share by Region (2018-2023)
    Table 9. World Medical Topical Hemostatic Agent Production Market Share by Region (2024-2029)
    Table 10. World Medical Topical Hemostatic Agent Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Medical Topical Hemostatic Agent Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Medical Topical Hemostatic Agent Major Market Trends
    Table 13. World Medical Topical Hemostatic Agent Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Medical Topical Hemostatic Agent Consumption by Region (2018-2023) & (K Units)
    Table 15. World Medical Topical Hemostatic Agent Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Medical Topical Hemostatic Agent Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Medical Topical Hemostatic Agent Producers in 2022
    Table 18. World Medical Topical Hemostatic Agent Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Medical Topical Hemostatic Agent Producers in 2022
    Table 20. World Medical Topical Hemostatic Agent Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Medical Topical Hemostatic Agent Company Evaluation Quadrant
    Table 22. World Medical Topical Hemostatic Agent Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Medical Topical Hemostatic Agent Production Site of Key Manufacturer
    Table 24. Medical Topical Hemostatic Agent Market: Company Product Type Footprint
    Table 25. Medical Topical Hemostatic Agent Market: Company Product Application Footprint
    Table 26. Medical Topical Hemostatic Agent Competitive Factors
    Table 27. Medical Topical Hemostatic Agent New Entrant and Capacity Expansion Plans
    Table 28. Medical Topical Hemostatic Agent Mergers & Acquisitions Activity
    Table 29. United States VS China Medical Topical Hemostatic Agent Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Medical Topical Hemostatic Agent Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Medical Topical Hemostatic Agent Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Medical Topical Hemostatic Agent Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Medical Topical Hemostatic Agent Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Medical Topical Hemostatic Agent Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Medical Topical Hemostatic Agent Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Medical Topical Hemostatic Agent Production Market Share (2018-2023)
    Table 37. China Based Medical Topical Hemostatic Agent Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Medical Topical Hemostatic Agent Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Medical Topical Hemostatic Agent Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Medical Topical Hemostatic Agent Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Medical Topical Hemostatic Agent Production Market Share (2018-2023)
    Table 42. Rest of World Based Medical Topical Hemostatic Agent Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Medical Topical Hemostatic Agent Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Medical Topical Hemostatic Agent Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Medical Topical Hemostatic Agent Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Medical Topical Hemostatic Agent Production Market Share (2018-2023)
    Table 47. World Medical Topical Hemostatic Agent Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Medical Topical Hemostatic Agent Production by Type (2018-2023) & (K Units)
    Table 49. World Medical Topical Hemostatic Agent Production by Type (2024-2029) & (K Units)
    Table 50. World Medical Topical Hemostatic Agent Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Medical Topical Hemostatic Agent Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Medical Topical Hemostatic Agent Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Medical Topical Hemostatic Agent Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Medical Topical Hemostatic Agent Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Medical Topical Hemostatic Agent Production by Application (2018-2023) & (K Units)
    Table 56. World Medical Topical Hemostatic Agent Production by Application (2024-2029) & (K Units)
    Table 57. World Medical Topical Hemostatic Agent Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Medical Topical Hemostatic Agent Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Medical Topical Hemostatic Agent Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Medical Topical Hemostatic Agent Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. Ethicon Basic Information, Manufacturing Base and Competitors
    Table 62. Ethicon Major Business
    Table 63. Ethicon Medical Topical Hemostatic Agent Product and Services
    Table 64. Ethicon Medical Topical Hemostatic Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Ethicon Recent Developments/Updates
    Table 66. Ethicon Competitive Strengths & Weaknesses
    Table 67. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 68. Pfizer Major Business
    Table 69. Pfizer Medical Topical Hemostatic Agent Product and Services
    Table 70. Pfizer Medical Topical Hemostatic Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Pfizer Recent Developments/Updates
    Table 72. Pfizer Competitive Strengths & Weaknesses
    Table 73. Baxter International Basic Information, Manufacturing Base and Competitors
    Table 74. Baxter International Major Business
    Table 75. Baxter International Medical Topical Hemostatic Agent Product and Services
    Table 76. Baxter International Medical Topical Hemostatic Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Baxter International Recent Developments/Updates
    Table 78. Baxter International Competitive Strengths & Weaknesses
    Table 79. C. R. Bard Basic Information, Manufacturing Base and Competitors
    Table 80. C. R. Bard Major Business
    Table 81. C. R. Bard Medical Topical Hemostatic Agent Product and Services
    Table 82. C. R. Bard Medical Topical Hemostatic Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. C. R. Bard Recent Developments/Updates
    Table 84. C. R. Bard Competitive Strengths & Weaknesses
    Table 85. The Medicines Company Basic Information, Manufacturing Base and Competitors
    Table 86. The Medicines Company Major Business
    Table 87. The Medicines Company Medical Topical Hemostatic Agent Product and Services
    Table 88. The Medicines Company Medical Topical Hemostatic Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. The Medicines Company Recent Developments/Updates
    Table 90. The Medicines Company Competitive Strengths & Weaknesses
    Table 91. Anika Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 92. Anika Therapeutics Major Business
    Table 93. Anika Therapeutics Medical Topical Hemostatic Agent Product and Services
    Table 94. Anika Therapeutics Medical Topical Hemostatic Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Anika Therapeutics Recent Developments/Updates
    Table 96. Anika Therapeutics Competitive Strengths & Weaknesses
    Table 97. Advanced Medical Solutions Basic Information, Manufacturing Base and Competitors
    Table 98. Advanced Medical Solutions Major Business
    Table 99. Advanced Medical Solutions Medical Topical Hemostatic Agent Product and Services
    Table 100. Advanced Medical Solutions Medical Topical Hemostatic Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Advanced Medical Solutions Recent Developments/Updates
    Table 102. Advanced Medical Solutions Competitive Strengths & Weaknesses
    Table 103. Integra LifeSciences Basic Information, Manufacturing Base and Competitors
    Table 104. Integra LifeSciences Major Business
    Table 105. Integra LifeSciences Medical Topical Hemostatic Agent Product and Services
    Table 106. Integra LifeSciences Medical Topical Hemostatic Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Integra LifeSciences Recent Developments/Updates
    Table 108. Integra LifeSciences Competitive Strengths & Weaknesses
    Table 109. B Braun Melsungen Basic Information, Manufacturing Base and Competitors
    Table 110. B Braun Melsungen Major Business
    Table 111. B Braun Melsungen Medical Topical Hemostatic Agent Product and Services
    Table 112. B Braun Melsungen Medical Topical Hemostatic Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. B Braun Melsungen Recent Developments/Updates
    Table 114. B Braun Melsungen Competitive Strengths & Weaknesses
    Table 115. Gelita Medical Basic Information, Manufacturing Base and Competitors
    Table 116. Gelita Medical Major Business
    Table 117. Gelita Medical Medical Topical Hemostatic Agent Product and Services
    Table 118. Gelita Medical Medical Topical Hemostatic Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. Gelita Medical Recent Developments/Updates
    Table 120. Gelita Medical Competitive Strengths & Weaknesses
    Table 121. Equimedical Basic Information, Manufacturing Base and Competitors
    Table 122. Equimedical Major Business
    Table 123. Equimedical Medical Topical Hemostatic Agent Product and Services
    Table 124. Equimedical Medical Topical Hemostatic Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 125. Equimedical Recent Developments/Updates
    Table 126. Equimedical Competitive Strengths & Weaknesses
    Table 127. Vascular Solutions Basic Information, Manufacturing Base and Competitors
    Table 128. Vascular Solutions Major Business
    Table 129. Vascular Solutions Medical Topical Hemostatic Agent Product and Services
    Table 130. Vascular Solutions Medical Topical Hemostatic Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 131. Vascular Solutions Recent Developments/Updates
    Table 132. Marine Polymer Technologies Basic Information, Manufacturing Base and Competitors
    Table 133. Marine Polymer Technologies Major Business
    Table 134. Marine Polymer Technologies Medical Topical Hemostatic Agent Product and Services
    Table 135. Marine Polymer Technologies Medical Topical Hemostatic Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 136. Global Key Players of Medical Topical Hemostatic Agent Upstream (Raw Materials)
    Table 137. Medical Topical Hemostatic Agent Typical Customers
    Table 138. Medical Topical Hemostatic Agent Typical Distributors
List of Figure
    Figure 1. Medical Topical Hemostatic Agent Picture
    Figure 2. World Medical Topical Hemostatic Agent Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Medical Topical Hemostatic Agent Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Medical Topical Hemostatic Agent Production (2018-2029) & (K Units)
    Figure 5. World Medical Topical Hemostatic Agent Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Medical Topical Hemostatic Agent Production Value Market Share by Region (2018-2029)
    Figure 7. World Medical Topical Hemostatic Agent Production Market Share by Region (2018-2029)
    Figure 8. North America Medical Topical Hemostatic Agent Production (2018-2029) & (K Units)
    Figure 9. Europe Medical Topical Hemostatic Agent Production (2018-2029) & (K Units)
    Figure 10. China Medical Topical Hemostatic Agent Production (2018-2029) & (K Units)
    Figure 11. Japan Medical Topical Hemostatic Agent Production (2018-2029) & (K Units)
    Figure 12. Medical Topical Hemostatic Agent Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Medical Topical Hemostatic Agent Consumption (2018-2029) & (K Units)
    Figure 15. World Medical Topical Hemostatic Agent Consumption Market Share by Region (2018-2029)
    Figure 16. United States Medical Topical Hemostatic Agent Consumption (2018-2029) & (K Units)
    Figure 17. China Medical Topical Hemostatic Agent Consumption (2018-2029) & (K Units)
    Figure 18. Europe Medical Topical Hemostatic Agent Consumption (2018-2029) & (K Units)
    Figure 19. Japan Medical Topical Hemostatic Agent Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Medical Topical Hemostatic Agent Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Medical Topical Hemostatic Agent Consumption (2018-2029) & (K Units)
    Figure 22. India Medical Topical Hemostatic Agent Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Medical Topical Hemostatic Agent by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Medical Topical Hemostatic Agent Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Medical Topical Hemostatic Agent Markets in 2022
    Figure 26. United States VS China: Medical Topical Hemostatic Agent Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Medical Topical Hemostatic Agent Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Medical Topical Hemostatic Agent Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Medical Topical Hemostatic Agent Production Market Share 2022
    Figure 30. China Based Manufacturers Medical Topical Hemostatic Agent Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Medical Topical Hemostatic Agent Production Market Share 2022
    Figure 32. World Medical Topical Hemostatic Agent Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Medical Topical Hemostatic Agent Production Value Market Share by Type in 2022
    Figure 34. Gelation Sponge
    Figure 35. Oxidized Regenerated Cellulose Based Hemostats
    Figure 36. Others
    Figure 37. World Medical Topical Hemostatic Agent Production Market Share by Type (2018-2029)
    Figure 38. World Medical Topical Hemostatic Agent Production Value Market Share by Type (2018-2029)
    Figure 39. World Medical Topical Hemostatic Agent Average Price by Type (2018-2029) & (US$/Unit)
    Figure 40. World Medical Topical Hemostatic Agent Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 41. World Medical Topical Hemostatic Agent Production Value Market Share by Application in 2022
    Figure 42. Hospitals
    Figure 43. Surgical Centers
    Figure 44. Nursing Homes
    Figure 45. World Medical Topical Hemostatic Agent Production Market Share by Application (2018-2029)
    Figure 46. World Medical Topical Hemostatic Agent Production Value Market Share by Application (2018-2029)
    Figure 47. World Medical Topical Hemostatic Agent Average Price by Application (2018-2029) & (US$/Unit)
    Figure 48. Medical Topical Hemostatic Agent Industry Chain
    Figure 49. Medical Topical Hemostatic Agent Procurement Model
    Figure 50. Medical Topical Hemostatic Agent Sales Model
    Figure 51. Medical Topical Hemostatic Agent Sales Channels, Direct Sales, and Distribution
    Figure 52. Methodology
    Figure 53. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Ethicon
Pfizer
Baxter International
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences
B Braun Melsungen
Gelita Medical
Equimedical
Vascular Solutions
Marine Polymer Technologies

Related Reports

Global Medical Topical Hemostatic Agent Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Medical Topical Hemostatic Agent Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

date 04 Aug 2022

date Pharma & Healthcare

The Medical Topical Hemostatic Agent market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Medical Topical Hemostatic Agent Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Medical Topical Hemostatic Agent Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 07 Aug 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Medical Topical Hemostatic Agent market size was valued at USD 8591.7 million in 2022 and is forecast to a readjusted size of USD 13610 million by 2029 with a CAGR of 6.8% during review period.

Global Medical Topical Hemostatic Agent Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Medical Topical Hemostatic Agent Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 13 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Medical Topical Hemostatic Agent market size was valued at USD 8591.7 million in 2023 and is forecast to a readjusted size of USD 13610 million by 2030 with a CAGR of 6.8% during review period.

Product Tags

medical topical hemostatic agent

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>